What is Zevra Therapeutics, Inc.'s EPS (diluted)?

Zevra Therapeutics, Inc. (ZVRA) reported EPS (diluted) of $0.60 in Q1 2026.

How has Zevra Therapeutics, Inc.'s EPS (diluted) changed year-over-year?

Zevra Therapeutics, Inc.'s EPS (diluted) increased by 1100.0% year-over-year, from -$0.06 to $0.60.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Zevra Therapeutics, Inc. ZVRA EPS (Diluted)

EPS (Diluted) at other companies

BioMarin PharmaceuticalsBMRN

$0.54-43.2%

Ultragenyx PharmaceuticalRARE

-$1.84-17.2%

XER

Xeris Biopharma Holdings, Inc.XERS

$0.01+117%

Eton Pharmaceuticals, Inc.ETON

$0.05+183%

Theravance BiopharmaTBPH

-$0.10+63.0%

Relay Therapeutics, Inc.RLAY

-$0.41+10.9%

Other financials

Income statement

See full

Revenue$36.2M+77.5%

Gross profit$34.3M+80.1%

Operating income$52.1M+1,073%

Net income$37.9M+1,323%

Balance sheet

See full

Cash & equivalents$95.6M+156%

Total debt$1.1M-98.1%

Total equity$205.8M+402%

Total assets$278.6M+61.3%

Cash flow

See full

Operating cash flow$6.1M+175%

CapEx$35.0K-64.6%

Free cash flow$6.1M+173%

Valuation

See full

Market cap$773.23M+56.4%

Enterprise value$678.78M+30.8%

P/E6.2×—

P/S6.3×-5.9×

Profitability

See full

Gross margin86.1%+7.2pp

Operating margin-103.9%-43.0pp

Net margin101.6%+60.1pp

FCF margin-75%-30.5pp

Returns & leverage

See full

Return on equity100.7%+60.3pp

Debt / equity0×-1.5×

Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s EPS (diluted)?: Zevra Therapeutics, Inc. (ZVRA) reported EPS (diluted) of $0.60 in Q1 2026.
How has Zevra Therapeutics, Inc.'s EPS (diluted) changed year-over-year?: Zevra Therapeutics, Inc.'s EPS (diluted) increased by 1100.0% year-over-year, from -$0.06 to $0.60.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.